Variant report
Variant | nsv967050 |
---|---|
Chromosome Location | chr3:110400878-110402669 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538296156 | chr3:110400884-110400885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs77150724 | chr3:110400961-110400962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376523259 | chr3:110401005-110401006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113398685 | chr3:110401054-110401055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs55740136 | chr3:110401110-110401111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531443666 | chr3:110401160-110401161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190454516 | chr3:110401193-110401194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559367876 | chr3:110401202-110401203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370997340 | chr3:110401247-110401248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs199694878 | chr3:110401313-110401314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568101200 | chr3:110401321-110401322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111339926 | chr3:110401325-110401326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550919356 | chr3:110401338-110401339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181443493 | chr3:110401416-110401417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs55633814 | chr3:110401432-110401433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539584474 | chr3:110401437-110401438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185880950 | chr3:110401449-110401450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138687611 | chr3:110401465-110401466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534817400 | chr3:110401471-110401472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs36104081 | chr3:110401486-110401487 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs189947900 | chr3:110401490-110401491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543687102 | chr3:110401491-110401492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557268829 | chr3:110401499-110401500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs181176001 | chr3:110401516-110401517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546353067 | chr3:110401519-110401520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559703266 | chr3:110401535-110401536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370424788 | chr3:110401571-110401572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186535676 | chr3:110401640-110401641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541989282 | chr3:110401656-110401657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561644577 | chr3:110401684-110401685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569520136 | chr3:110401695-110401696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142268271 | chr3:110401697-110401698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550609295 | chr3:110401736-110401737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs4510407 | chr3:110401766-110401767 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs7615275 | chr3:110401792-110401793 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs142427477 | chr3:110401793-110401794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139723562 | chr3:110401814-110401815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112005379 | chr3:110401872-110401873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs566590305 | chr3:110401884-110401885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534790022 | chr3:110401932-110401933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554672600 | chr3:110401948-110401949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568099891 | chr3:110401980-110401981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs182717252 | chr3:110401995-110401996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144390217 | chr3:110402001-110402002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs367722237 | chr3:110402028-110402029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144518827 | chr3:110402047-110402048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148429634 | chr3:110402051-110402052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537820833 | chr3:110402054-110402055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187256455 | chr3:110402062-110402063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs55972144 | chr3:110402063-110402064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Developmental delay | 22180640 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:110397000-110402600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr3:110398400-110402600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:110398400-110402800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr3:110398400-110404600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr3:110398600-110403000 | Weak transcription | Fetal Lung | lung |
6 | chr3:110400000-110404600 | Weak transcription | Fetal Brain Male | brain |
7 | chr3:110400400-110401000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr3:110400800-110402400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
9 | chr3:110401000-110402800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr3:110402400-110406800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr3:110402600-110402800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr3:110402600-110403200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr3:110402600-110403400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
14 | chr3:110402600-110403600 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr3:110402600-110403800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
16 | chr3:110402600-110404000 | Enhancers | H9 Cell Line | embryonic stem cell |
17 | chr3:110402600-110404600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
18 | chr3:110402600-110404800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
19 | chr3:110402600-110406600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |